Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 0 | 0 | 0 | 190 | 0 |
| Gross Profit | N/A | N/A | N/A | 190 | N/A |
| Operating Expenses | 10,881 | 11,436 | 14,796 | 26,935 | 20,313 |
| Operating Income | -10,881 | -11,436 | -14,796 | -26,745 | -20,313 |
| Other Income | 571 | 644 | 832 | 999 | 781 |
| Pre-tax Income | -10,310 | -10,792 | -13,964 | -25,746 | -19,532 |
| Net Income Continuous | -10,310 | -10,792 | -13,964 | -25,746 | -19,532 |
| Minority Interests | 1 | 1 | -9 | 2 | 1 |
| Net Income | $-10,309 | $-10,792 | $-13,962 | $-25,744 | $-19,531 |
| EPS Basic Total Ops | -0.11 | -0.11 | -0.15 | -0.26 | -0.22 |
| EPS Basic Continuous Ops | -0.11 | -0.11 | -0.14 | -0.27 | -0.22 |
| EPS Diluted Total Ops | -0.11 | -0.11 | -0.15 | -0.26 | -0.22 |
| EPS Diluted Continuous Ops | -0.11 | -0.11 | -0.14 | -0.27 | -0.22 |
| EPS Diluted Before Non-Recurring Items | -0.11 | -0.11 | -0.14 | -0.26 | -0.22 |
| EBITDA(a) | $-10,622 | $-11,297 | $-14,763 | $-26,868 | $-20,384 |